Life Cycle
Has 2 hosts: vertebrate (intermediate) and mosquito (definitive) |
Definitive Host: Sporulating Cycle (Sporogony) |
Intermediate Host: Asexual Cycle (Schizogony) |
EXO-ERYTHROCYTIC CYCLE |
1. Anopheles mosquito (definitive host), inoculates sporozoites into human host (intermediate) |
Sporozoites are the infective stage to man |
2. Sporozoites infect liver parenchymal cells and mature into schizonts, which produce merozoites |
P. vivax and P. ovale assume a dormant stage (hypnozoites), and can persist in the liver |
3. Infected cell ruptures and releases merozoites |
ERYTHROCYTIC CYCLE |
4. Merozoites infect RBCs and become trophozoites (ring stage) |
Merozoites are the infective stage for RBCs |
5. Trophozoites mature into schizonts, which rupture and release merozoites |
Some differentiate into gametocytes, which are ingested by the mosquito looking for a blood meal |
6. Ruptured schizonts are responsible for the clinical manifestations of the disease |
SPOROGONIC CYCLE |
7. The gametocytes are ingested by an anopheles mosquito and make their way into the stomach of the mosquito |
8. While in the stomach, the microgametes (male) penetrate the macrogametes (female), which generate zygotes |
Microgametocyte exflagellates and produces 8 sperm-like microgametes |
9. The zygotes become motile and elongated |
These are called ookinetes |
10. The ookinetes invade the midgut wall of the mosquito, where they develop into oocysts |
11. The oocysts grow, rupture, and release sporozoites, which makes their way into the salivary glands of the mosquito |
12. Inoculation of the sporozoites into a new human host perpetuates the malaria life cycle |
The merozoite recognizes a specific receptor site on the RBC and exposes several organelles for attachment. The red cells becomes deformed and the merozoite enters through an invagination of the RBC membrane
For P. vivax, the receptor site on the RBC is associated with the Duffy Blood Group Antigen. Over 90% of Africans are Duffy Negative and are resistant to Vivax Malaria
Pathogenicity and Virulence
Pathological process is the result of erythrocytic cycle |
1. Hemolysis |
|
RBC invasion by merozoites induces changes in cytoskeleton and decreases in deformability |
|
Increased capillary permeability, which allows fluid to lead into surrounding tissues, causing congestion in blood vessels and tissue infarction and necrosis |
2. Liberation of Metabolites |
|
Rupture of RBCs bring on malarial paroxysm and increased hemosiderin in the liver, spleen, and other organs, which become black in color |
|
Lysis of cells & phagocytosis of cell remnants, debris, and hemozoin congest the kupffer cells of the liver, resulting in hepatosplenomegaly. Tears of splenic capsule may occur due to trauma or coughing & may require surgery |
3. Immunologic Response |
|
Antigens of P. falciparum induces cytokines, which stimulate the release of TNF or Cachexin, which causes fever, paroxysms, HA, pains, and prostration |
|
TNF produces neurologic symptoms, which play a role in cerebral malaria |
|
Repeated attacks of malaria produce anemia |
|
Immune complexes are formed and may be deposited in the kidney |
4. Formation of Malarial Pigment |
|
In infected RBC, Hgb is digested forming the pigment hemozoin, which can get deposited to various organs |
|
Hemozoin formation depletes iron stores, which leads to anemia |
VIRULENCE FACTORS |
Knobs develop for adhesion to parasitized and non-parasitized cells and platelets |
|
P. falciparum erythrocyte membrane Pr1 (PfEMP1) is the most adhesive protein among the knobs |
|
Knobs contain Histidine-Rich Pr (HRP) |
|
In Falciparum, cytoadherence causes plugging of small vessels by masses of parasitized RBCs and RBCs sticking to endothelium causing: ischemia of the brain, heart, kidney, lungs, and GIT |
PREFERENCE |
Vivax and Ovale |
Only reticulocytes and young RBC |
Malariae |
Senescent cells |
infections with these 3 parasites (vivax, ovale, and malariae) limits number of RBCs that can be parasitized to less than 3% of all erythrocytes |
Falciparum and Knowlesi |
All ages of RBC |
Results in increased parasitemia, early anemia, and increased severity of complications and mortality |
|
|
Morphology
Ring Form (Early Trophozoite) |
Earliest stage after invasion of RBC. The ring has a dot-like nucleus of red chromatin |
Falciparum ring: headphone type with a double chromatin dot. |
Plasmodium Falciparum Ring Form
Headphone type is also seen in P. knowlesi
Plasmodium Malariae Bird's Eye Ring Form
Mature Trophozoites
The erythrocyte hemoglobin is metabolized to produce a darkly staining pigment hemozoin |
Maurer's Clefts: P. falciparum infections containing older ring-form trophozoites and asexual stages |
Schüffner's Dots: seen in P. vivax and P. ovale |
Parasite nutrition is hemoglobin and the metabolite is hemozoin or hematin
Schizont
When parasite divides and shows multiple masses of nuclear chromatin. Mature schizonts contain merozoites.
Rarely seen in peripheral blood of P. falciparum except in severe infections
Falciparum schizonts stay in capillaries of organs and muscles. If schizont spills into general circulation, indicates bad prognosis
Gametocytes
Sexual form ingested by the mosquito (infective stage for mosquito) |
Macrogametocyte: nucleus is dense and compact |
Microgametocyte: nucleus is a pale, loose network |
Knowlesi Gametocyte
Gametocytes of vivax, ovale, malariae, and knowlesi are similar, except that malariae is smaller and darker
Diagnosis
MICROSCOPIC IDENTIFICATION |
|
Gold standard |
|
Specimens can be taken any time |
|
Giemsa stain is preferred for visualization of certain structures (ex. Maurer's Clefts) |
|
If high degree of synchrony exist, late developmental stages can be demonstrated in the repeated smears every 4-6hrs (not recommended for falciparum) |
|
Repeated testing is not recommended if parasites are not found initially |
|
Blood smears are obtained to monitor response to treatment |
|
Thick Film: reveals if parasite is present and is most efficient method of detection |
|
Thin Film: identification of species |
MALARIAL RDT |
|
Uses Immunochromatography to detect Plasmodium specific antigens in a finger prick blood sample |
|
Antigens utilized are: HRP II, pLDH, Plasmodium Aldolase |
|
HRP II: produced by trophozoites and young gametocytes of P. falciparum |
|
pLDH: produced by both sexual and asexual stages, and can distinguish between falciparum and non-falciparum. Sensitive for severe malaria |
|
Plasmodium Aldolase: PA + HRP II = PMA which has 90% specificity and can be performed in 30 minutes |
SEROLOGY |
Cannot differentiate past from current infection |
|
Indirect Hemagglutination (IHA) |
|
Indirect Fluorescent Antibody Test (IFAT) |
|
ELISA |
PCR |
low parasitemia or mixed infection |
|
|
Plasmodium Falciparum
MALIGNANT TERTIAN MALARIA |
|
Also known as subtertian or Aestivoautumnal Malaria |
|
Deadliest species of plasmodium |
|
Causes 50% of all malaria cases |
|
Erythrocytic cycle of 48hrs |
|
Found in tropics, subtropics, and sub saharan Africa |
|
Infected cell is same size as normal RBC |
|
Associated with the development of Burkitt's Lymphoma |
RING-FORM TROPHOZOITES |
|
Headphone Type: Rings may possess 1 or 2 chromatin dots |
|
They may be found on the periphery of the RBC (accolé, appliqué) and multiply-infected RBCs may be seen. |
|
Usually no enlargement of infected RBC |
|
Maurer's Clefts: can be seen in infections w/ older ring-form trophozoites, and resembles the Schüffner’s dots but are larger and coarser |
DEVELOPING AND OLDER TROPHOZOITES |
|
Remain in ring-form, but may become thicker and more compact |
|
Amount of pigment and chromatin may also increase |
SCHIZONTS |
|
Schizogony DOES NOT take place in the peripheral blood, but in capillaries of organs and muscles. |
|
The only stages seen in peripheral blood are rings and gametocytes |
|
Contain anywhere from 8-24 merozoites |
|
Mature schizont usually fills 2/3 of infected RBC |
GAMETOCYTES |
|
Crescent or sausage or banana shaped |
|
Pigment is more coarse and concentrated in macrogametocyte than microgametocyte |
|
Laveran's Bib: remnants of host RBC |
Plasmodium Ovale
OVALE MALARIA |
|
Has an erythrocytic cycle of 48hrs |
|
Has a hypnozoite stage in the liver, which is the cause of relapse |
|
Infected RBC is slightly enlarged compared to normal RBC |
|
Found in Tropical Africa, West Africa, South America, and Asia |
RING-FORM TROPHOZOITES |
|
Contains single chromatin dot. Difficult to differentiate from vivax. |
|
Multiply-Infected RBC may be see |
MATURE TROPHOZOITES |
|
As trophozoite matures, infected RBCs may exhibit fimbriation and Schüffner’s dots |
SCHIZONTS |
|
Similar to P. vivax, though tend to contain fewer merozoites (4-16, on average 8) |
|
Elongation to an oval shape and fimbriation are common |
|
Schüffner’s dots can be observed with proper staining |
GAMETOCYTES |
|
Difficult to distinguish from P. vivax |
|
Slight enlargement of infected RBC |
Plasmodium Vivax
BENIGN TERTIAN MALARIA |
|
Erythrocytic cycle of 48 hours |
|
Hypnozoite: persistant dormant stage in the liver, which is the cause of relapse |
|
Predominant malarial species |
|
Infected RBC is enlarged due to affinity for young RBCs or reticulocytes |
RING-FORM TROPHOZOITES |
|
Has a thick cytoplasm w/ single, large chromatin dot. Difficult to distinguish from P. ovale |
|
Cytoplasm becomes ameboid and Schüffner’s dots may appear as trophozoites mature |
LATE TROPHOZOITES |
|
Developing trophozoites become amoeboid, with pseudopodial processes and large vacuoles. Schüffner’s dots are visible with proper staining |
|
band-form appearance of trophozoite may occur |
|
May be mistaken for P. Malariae or P. knowlesi |
SCHIZONTS |
|
Pigment is organized in 1-2 clumps |
|
Mature schizonts contain 12-24 merozoites, each of which contains a dot of chromatin and a mass of cytoplasm |
GAMETOCYTE |
|
Macrogametocyte: round to oval and usually fill host cell. Infected RBC is larger and cytoplasm is usually a darker blue with fine brown pigments throughout |
|
Microgametocyte: usually the size of an uninfected RBC and has a paler blue, pink or grey cytoplasm |
Plasmodium Knowlesi
KNOWLESI MALARIA |
|
Vector is A. balabacensis & A. maculatus |
|
Primate malaria in macaques in South East Asia |
|
Infects ALL stages of RBC, and causes severe malaria |
|
Erythrocytic cycle has quotidian pattern (every 24hrs) |
|
Non-relapsing due to absence of hynozoites |
|
Microscopically indistinguishable from P. malariae (Use PCR to distinguish) |
|
Quotidian pattern results in high levels of parasitemia and severe disease with fatal consequence |
TREATMENT |
|
Chloroquine |
|
Primaquine |
|
Should be treated aggressively and urgently |
RING-FORM TROPHOZOITES |
|
Normal to 0.75x smaller than uninfected RBC |
|
Rings may show double chromatin dots |
|
Appliqué forms may be seen as well as rectangular rings harboring one or more accessory chromatin dots |
|
RBC may be Multiply-infected |
OLDER, DEVELOPING TROPHOZOITES |
|
Band forms may appear similar to P. malariae |
|
Sinton and Mulligan's stippling may appear |
SCHIZONTS |
|
Sinton and Mulligan's stippling may appear |
|
10-16 merozoites |
Gametocytes |
|
Mature Macrogametocyte: usually spherical and fill the host RBC. Cytoplasm stains blue and eccentric nucleus stains red |
|
Microgametocyte: smaller and cytoplasm stains pale pink, while nucleus stains a darker red |
Plasmodium Malariae
QUARTAN MALARIA |
|
Erythrocytic cycle of 72hrs |
|
Found in subtropical and temperate areas |
|
Infected cells are normal to smaller in size than most RBCs |
|
Old cells are preferentially infected** |
RING-FORM TROPHOZOITES |
|
Have 1 chromatin dot and a cytoplasm ring that is thicker than P. falciparum. |
|
Infected RBC is normal to smaller |
|
Bird's-eye forms may appear |
MATURE TROPHOZOITES |
|
Rounded chromatin and compact cytoplasm |
|
As the trophozoite matures, the cytoplasm may elongate across the host RBC, forming a band-form |
|
Pigment granules become larger and tend to have a more peripheral arrangement |
|
Zeimann's stippling may be present |
SCHIZONTS |
|
6-12 merozoites, often arranged in a rosette or irregular cluster |
|
Mature schizonts nearly fill the normal-sized host |
GAMETOCYTES |
|
Compact and fills* host RBC |
|
Sometimes, there is a reduction in size of the infected RBC |
|
Cytoplasm stains blue and the chromatin is pink to red. |
|
Abundant dark pigment may be scattered throughout the cytoplasm |
Band forms are present in malariae, vivax, and knowlesi
|
|
Clinical Manifestations
PRE-PATENT PERIOD |
Interval from sporozoite injection to detection of parasites in blood |
|
P.falciparum: 11-14 days |
|
vivax: 11-15 days |
|
ovale: 14-26 days |
|
malariae: 3-4 weeks |
|
knowlesi: 9-12 days |
INCUBATION PERIOD |
time between sporozoite injection and appearance of clinical symptoms (8-40) |
|
falciparum: 8-15 days |
|
vivax: 12-20 days |
|
ovale: 11-16 days |
|
malariae: 18-40 days |
|
knowlesi: 5 days- few weeks |
PRODROMAL SYMPTOMS |
Weakness, exhaustion, aching bones, limbs, and back; loss of appetite; nausea; vomiting |
|
malaise, backache, diarrhea, and epigastric discomfort |
MALARIAL PAROXYSM |
1. Cold Stage |
|
Sudden feelings of coldness and apprehension |
|
Mild shivering quickly turns to violent teeth chattering and shaking of entire body |
|
Vomiting may occur |
|
Rigors last for 15min-1hr, then stops |
2. Hot Stage or Flush Phase |
|
Patient becomes hot (41° C ), with headache, palpitations, tachypnea, epigastric discomfort, thirst, nausea, and vomiting |
|
Skin is hot and flushed, patient is confused and delerious |
|
Lasts 2-6hrs |
3. Sweating Stage |
|
Defervesence and diaphoresis or profuse sweating occurs |
|
Temperature lowers in the next 2-4hrs and symptoms diminish accordingly |
|
Total duration is 8-12hrs |
Periodicity of attack only occurs if patient is left untreated |
Interval length is determined by length of erythrocytic cycle |
|
falciparum, vivax and ovale – 48 hours |
|
malariae – 72 hours |
|
knowlesi – 24 hours |
COMPLICATIONS |
Vivax, ovale and quartan malaria are relatively benign |
Knowlesi |
|
Severe thrombocytopenia, jaundice, deranged liver enzymes. |
|
Acute Respiratory Distress Syndrome with tachypnea, hypoxemia, and pulmonary infiltrates on CXR. |
|
Acute Renal Failure with elevated serum creatinine |
|
Hypotension |
|
Acidosis |
Chronic Malariae |
|
immune-complex deposition on the glomerular walls, leading to nephrotic syndrome in children |
Falciparum |
|
Cerebral Malaria (requires prompt administration of quinidine IV and then quinine PO) |
|
Anemia |
|
Acute Renal Failure (tubular necrosis and nephrotic syndrome) |
|
Blackwater fever: from massive intravascular hemolysis and hemoglobinuria |
|
Dysenteric Malaria |
|
Algid Malaria: rapid development of hypotension and impairment of vascular perfusion |
|
Pulmonary Edema |
|
Tropical Splenomegaly Syndrome |
|
Hyperparasitemia (>10-20% of RBC mean high mortality rate) |
|
Hypoglycemia |
Treatment
Proper use of the antimalarial drugs is based on knowledge of their effects on the parasite at various stages of the life cycle |
Suppressive therapy: |
destroy the parasites as they enter the bloodstream; effective against the erythrocytic stages. |
Clinical Cure: |
full and rapid elimination of plasmodiumfrom the blood to prevent complications |
Radical cure: |
elimination of not only the bloodstream infection but the tissue stages in the liver as well. |
BLOOD SCHIZONTICIDES |
Clinical cure of an acute attack, no effect on pre-erythrocytic and gametocyte stage |
1. Quinine |
blood schizonticide against all five species of human malarial parasites. Side effects of treatment include tinnitus and headache, vertigo |
2. Quinidine |
3. Chloroquine |
4. Amodiaquine |
5. Mefloquine |
effective against both chloroquine-sensitive and –resistant strains of P. falciparum and P. vivax. It is also effective against P. malariae and P. ovale |
6. Doxycycline |
7. Proguanil |
Prevents development of oocysts in mosquito |
8. Halofantrine |
9. Artemisinin |
effective against P. falciparum , P. knowlesi and P. vivax, and in patients with cerebral malaria |
TISSUE SCHIZONTICIDES |
destroy the developmental stages in the liver |
1. Primaquine |
effective against the hypnozoites of P. vivax and P. ovale. |
*GAMETOCYTICIDES |
1. Primaquine |
gametocyticidal for all five species of malaria parasites and acts to render the patient noninfectious to the mosquito |
UNCOMPLICATED P. FALCIPARUM |
1. Atovaquone-Proguanil |
(Malarone™) 4 adult tabs po qd x 3 days |
2. Artemether-Lumefantrine |
(Coartem™) 1 tablet = 20mg artemether and 120 mg lumefantrine . 4 tabs initial dose, followed by 4 tabs as second dose 8 hours later, then 4 tabs po bid for the following 2 days. |
3. Quinine Sulfate |
plus one of the following: Doxycycline, Tetracycline, or Clindamycin (for pregnant) |
4. Mefloquine |
CHLOROQUINE-SENSITIVE FALCIPARUM OR UNCOMPLICATED P. MALARIAE |
1. Chloroquine phosphate |
UNCOMPLICATED P. VIVAX OR OVALE |
1. Chloroquine phosphate plus Primaquine phosphate |
CHLOROQUINE RESISTANT VIVAX |
1. Quinine sulfate plus either Doxycycline or Tetracycline plus Primaquine phosphate |
SEVERE MALARIA |
1. Quinidine gluconate plus one of the following: Doxycycline, Tetracycline, or Clindamycin |
2. Exchange transfusion has been recommended for very severe falciparum malaria associated with high parasitemia ( >10% of RBCs ) |
P. KNOWLESI |
Uncomplicated |
1. Chloroquine |
2. Primaquine |
Severe |
1. Quinine |
2. Artemether-Lumefantrine |
MALARIA PROPHYLAXIS |
1.Atovaquone/Proguanil |
2. Doxycycline |
3. Chloroquine |
4. Mefloquine |
5. Primaquine |
|
Created By
Metadata
Comments
Yrenelu13, 11:26 24 Aug 22
Amazing job❤️
Add a Comment
Related Cheat Sheets